Medical News

RSS

ConjuChem files voluntary assignment in bankruptcy

ConjuChem Biotechnologies Inc. announced today that it has filed a voluntary assignment in bankruptcy under the Bankruptcy and Insolvency Act (Canada) in order to effect an orderly liquidation of its assets, property and operations.

22 Jul 2010

Zargis Medical receives U.S. Army contract to develop investigational device based on Signal-X6 systems

Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp., today announced that it received a contract from the U.S. Army to develop an investigational device based on the success of the Signal-X6 telemedicine systems recently deployed to the Army under a separate contract.

22 Jul 2010

Accommodating patients may help reduce racial health disparities, improve patient satisfaction: Study

What if an emergency room patient wants a different doctor than the one who reports to their examination room? If the patient is a woman or a racial minority, emergency physicians are more likely to honor their request to see a doctor of their same gender, race or religious background.

22 Jul 2010

Columbia Asia opens new 82-bed medical facility in Nusajaya, Malaysia

Columbia Asia, a fast-growing hospital company with Pacific Northwest roots, is now part of a major new development in Nusajaya, Malaysia - a mere 10-minute drive from the bustling country of Singapore.

22 Jul 2010

Uroplasty intends to offer shares of common stock in underwritten public offering

Uroplasty, Inc. announced today that it intends, subject to market and other conditions, to offer shares of its common stock in an underwritten public offering. Uroplasty also intends to grant the underwriters of the offering an option to purchase additional shares of common stock to cover over-allotments, if any.

22 Jul 2010

Prototype ring with sensors helps to detect, prevent preterm labor

The birth of a baby is usually a joyous event, but when a child is born too early, worrisome complications can occur, including serious health problems for the baby and steep medical bills for the family. To address this, Johns Hopkins graduate students and their faculty adviser have invented a new system to pick up very early signs that a woman is going into labor too soon.

22 Jul 2010

Onconase, Amphinase 2 show positive results for SARS virus: Tamir Biotechnology

Tamir Biotechnology, Inc. announced today that scientists supported by the National Institute of Allergy and Infectious Diseases confirmed that testing of two (2) of the company's compounds Onconase (Ranpirnase), and recombinant Amphinase 2 showed positive in vitro results for Severe Acute Respiratory Syndrome, also known as (SARS) virus.

22 Jul 2010

Sentry Equipment announces acquisition of AquatiPro

Sentry Equipment Corp, a leading worldwide supplier of industrial sampling products and systems, announces the acquisition of assets owned by AquatiPro, LLC, a multi-vendor service organization specializing in professional and maintenance repair services that support water and steam sample conditioning equipment, monitoring devices and analyzers.

22 Jul 2010

'Mystery patients' study says doctors can miss health's social determinants

Chicago Tribune: So-called "mystery patients" are showing that doctors often ignore or fail to ask about social determinants when it comes to health outcomes, a recent study suggests, for exampel, testing an emaciated patient for cancer before asking if he got enough to eat (he didn't).

22 Jul 2010

Study links application of disinfectants in recreational pools to adverse health outcomes

Splashing around in a swimming pool on a hot summer day may not be as safe as you think. A recent University of Illinois study links the application of disinfectants in recreational pools to previously published adverse health outcomes such as asthma and bladder cancer.

22 Jul 2010

Amylin reports $164.4M total revenue for quarter ended June 30, 2010

Amylin Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2010. The Company reported total revenue of $164.4 million for the quarter ended June 30, 2010, which includes net product sales of $162.5 million. Net loss, excluding a restructuring charge of $3.4 million, was $40.8 million, or $0.28 per share.

22 Jul 2010

Applied Spine Technologies receives U.S. Patent for stabilization device with travel-limiting functionality

Applied Spine Technologies, a medical device company focused on motion preservation of the lumbar spine, received a Notice of Allowance on July 12, 2010 from the U.S. Patent and Trademark Office. To be clinically useful, a dynamic stabilization device needs to allow the spine to move, but not move excessively.

22 Jul 2010

Physicians Practice, Wolfson Children's Hospital to help doctors manage patient care in Jacksonville area

Physicians Practice and Wolfson Children's Hospital have joined forces to help provide area physicians and their staff more time to devote to patient care. This new partnership is a unique program designed to help doctors in the Jacksonville area better handle the cumbersome and time-consuming issues of managing a busy practice.

22 Jul 2010

Onyx begins Phase 3 trial of carfilzomib in combination with lenalidomide, dexamethasone for relapsed myeloma

Onyx Pharmaceuticals, Inc. today announced that the company has begun enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed multiple myeloma. The company has an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) and received Scientific Advice from the European Medicines Agency (EMA) on the design and planned analysis of the ASPIRE trial.

22 Jul 2010

Hospital updates: ERs try to shorten waits, Florida Children's Hospital to join with Johns Hopkins

To attract patients, hospitals are increasingly posting wait times for their emergency rooms "on billboards, websites, social media outlets like Twitter and in text messages," The Salt Lake Tribune reports. "It's a competitive strategy, but also a tool for bending the wait-time curve and, hopefully, improving patient care, said Mary Joe Jones, chief clinical nursing officer at St. Mark's Hospital in Salt Lake City."

22 Jul 2010

Capsaicin may cause weight loss, fight fat buildup: Study

Capsaicin, the stuff that gives chili peppers their kick, may cause weight loss and fight fat buildup by triggering certain beneficial protein changes in the body, according to a new study on the topic. The report, which could lead to new treatments for obesity, appears in ACS' monthly Journal of Proteome Research.

22 Jul 2010

Eli Lilly CEO says U.S. drugmakers' biggest challenge is sustaining innovation

USA Today/Indianapolis Star: Drugmakers are facing an array of challenges, like lawsuits and patent losses, but also new opportunities including global growth and an expected surge in the number of U.S. residents with health insurance. Eli Lilly CEO John Lechleiter comments in a Q&A: "The biggest challenge facing the industry is to be able to sustain the flow of innovative medicines from our pipelines that can effectively compete against the generic versions of our own products" (Chu, 7/21).

22 Jul 2010

Study shows how muscle, fat could play role in survival of heart failure patients

University of Alberta research has discovered heart failure patients with more muscle have the potential to increase their length of life. Antigone Oreopoulos, a researcher from the U of A's School of Public Health, studied 140 patients with heart failure. Study participants underwent a special scan to measure their muscle mass and body fat.

22 Jul 2010

BSD provides additional information to FDA for 510(k) submission of MicroThermX Microwave Ablation System

BSD Medical Corporation today announced that it has provided the additional information requested by the U.S. Food and Drug Administration (FDA) for review of the 510(k) submission the Company filed for premarket clearance of the Company's Phase II MicroThermX® Microwave Ablation System (MTX-180) for ablation of soft tissue.

22 Jul 2010

Ingen revenues increase 1,139% for year ending May 31, 2010

Ingen Technologies, Inc., an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company revenues have increased from $10,401 reported in May 31, 2009, to $128,917 ending May 31, 2010. This is an increase of 1,139%.

22 Jul 2010

Medical News

ConjuChem files voluntary assignment in bankruptcy

Zargis Medical receives U.S. Army contract to develop investigational device based on Signal-X6 systems

Accommodating patients may help reduce racial health disparities, improve patient satisfaction: Study

Columbia Asia opens new 82-bed medical facility in Nusajaya, Malaysia

Uroplasty intends to offer shares of common stock in underwritten public offering

Prototype ring with sensors helps to detect, prevent preterm labor

Onconase, Amphinase 2 show positive results for SARS virus: Tamir Biotechnology

Sentry Equipment announces acquisition of AquatiPro

'Mystery patients' study says doctors can miss health's social determinants

Study links application of disinfectants in recreational pools to adverse health outcomes

Amylin reports $164.4M total revenue for quarter ended June 30, 2010

Applied Spine Technologies receives U.S. Patent for stabilization device with travel-limiting functionality

Physicians Practice, Wolfson Children's Hospital to help doctors manage patient care in Jacksonville area

Onyx begins Phase 3 trial of carfilzomib in combination with lenalidomide, dexamethasone for relapsed myeloma

Hospital updates: ERs try to shorten waits, Florida Children's Hospital to join with Johns Hopkins

Capsaicin may cause weight loss, fight fat buildup: Study

Eli Lilly CEO says U.S. drugmakers' biggest challenge is sustaining innovation

Study shows how muscle, fat could play role in survival of heart failure patients

BSD provides additional information to FDA for 510(k) submission of MicroThermX Microwave Ablation System

Ingen revenues increase 1,139% for year ending May 31, 2010

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News